Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Prevention of Chemotherapy-Induced Diarrhea in Metastatic Colorectal Cancer
NCT00037180Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Apr 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diarrhea comparing Celecoxib + Chemo with Placebo + Chemo (2 arms). Primary endpoint: Incidence of NCI CTC grade 2-4 diarrhea. Started Apr 2002; status: terminated.
02
Drugs
celecoxib
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT00037180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037180.